Hmm. I immediately went to read, because a once-a-week insulin would be amazing. But they don't name the insulin, just say that it's a new ultra-long. What really caught my eye was their comparison to the current human long-lasting insulins. "Currently, long-lasting insulins are available in human medicine, but the injections only control blood-sugar levels for two or three days." Those would be Lantus and Lev, I'm assuming

Although the claim of control over 2 to 3 days with just a long-lasting is -- very misleading. Or outright false. Or Dr. Mahony meant to say 'ultra-long' instead of just 'long'. The human ultra-longs I'm familiar with are Toujeo (insuling glargine u300) and Tresiba (insulin degludec u100, u200), and at least with Tresiba a human can get 2 day coverage -- although it
is a once-a-day insulin.
However, I'm in a position to say that Tresiba in cats is very much a BID insulin

Before Dr. Mahony expands the trial to include cats, I hope she takes note of the few of us already using ultra-longs. I know medicine can't progress without trials, but it hurts my heart to think of sugar kitties stuck in a trial where they're not getting nearly enough insulin to keep them healthy. I hope I'm wrong, but... I have a nightmare image of my head of a lot of cats in DKA by the end of their time in the trial.